SEC Form 4 · accession 0001209191-17-033952
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pernock
Officer — Pres. & Chief Comm. Officer
Period of report
May 19, 2017
Accepted (ET)
May 19, 2017 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2017 | P | 255 | $79.69 | A | 966 | D |
Table II — derivative securities
No Table II lines on this filing.